iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics.
Ibio stock last closed at $0.30, up 4.12% from the previous day, and has decreased 93.35% in one year. It has underperformed other stocks in the Biotechnology industry by 0.6 percentage points. Ibio stock is currently +15.65% from its 52-week low of $0.26, and -93.3% from its 52-week high of $4.53.
At the moment, there are 27.59M shares of IBIO outstanding. The market cap of IBIO is $8.36M. In the last 24 hours, 158,125 IBIO shares were traded.
How to Buy Ibio Stock
Wondering how to invest in Ibio stock? Here's how.
Choose where to buy Ibio stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you figure out where to buy Ibio stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit funds into your brokerage account: Choose your payment method and add your info.
Evaluate Ibio stock: The Ibio ticker symbol is IBIO. Is Ibio stock a good investment? Should you buy shares of IBIO? How do IBIO's underlying business fundamentals look? Do top analysts think Ibio is a good buy? Why has IBIO's stock price moved recently? (Hint: Our stock research website can help you decide if IBIO is a good stock to buy).
Place your IBIO buy order: Decide if you will purchase IBIO shares at the current market price or use a limit order to purchase IBIO shares at a given price.
Track your investment in IBIO: Create a watchlist to important updates regarding your position in Ibio shares.
Step 1: Choose where to buy Ibio stock
You will need a brokerage account in order to access the NYSEMKT market and buy IBIO shares.
A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best brokerage. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global financial markets: From Technology to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading stock exchanges.
Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected the best brokerage, you need to fill out some personal info so you can invest in IBIO stock today.
Once you have decided on the best place to buy Ibio stock, it's crucial to analyze their stock prior to investing, so you can comprehend the risk and upside.
Ibio Metrics
IBIO Price
$0.30
1w %
-2.26%
1y %
-93.35%
5y %
-98.57%
P/E
-0.06x
P/B
0.54x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$65.01M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$8.36M
Next Earnings
Nov 13, 2023
Next Dividend
N/A
IBIO Overview
WallStreetZen was designed to help everyday investors perform better fundamental analysis.
There are more short-term assets than short-term liabilities on the IBIO balance sheet.
There are more short-term assets than long-term liabilities on the IBIO balance sheet.
Failed Health Checks:
Total IBIO debt is higher than 5 years ago, relative to shareholder equity.
IBIO has a relatively high debt to equity ratio of 1.68.
IBIO has cash burn of 33574000. It does not have enough cash and short-term investments to cover this.
IBIO has $7.58M in cash and short term investments. This is not enough to cover its annual cash burn of $33.57M.
IBIO Technical Indicators
SMA10
0.31
SMA20
0.31
SMA50
0.39
SMA100
0.57
SMA200
0.86
MACD
-0.02
MACD Signal
-0.03
MACD Histogram
0
RSI
41.19
Stochastic %K
13.33
Stochastic %D
15.8
StochRSI %K
31.83
StochRSI %D
37.29
IBIO Performance Metrics
Last year, IBIO revenue was $0.00. Over the past five year, IBIO's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 108.28%.
In the last 12 months, insiders at IBIO have sold more shares than they have bought.
Martin Brenner, Chief Executive Officer and Chief Scientific Officer of IBIO, was the latest IBIO insider to sell. They sold $1,528.36 worth of IBIO shares on Aug 28, 2023.
No, Ibio doesn't provide an income stream by paying out dividends.
What others are saying about IBIO
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your IBIO buy order
You have two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are generally fine for most investors.
Limit order: A limit order is an order to buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at a given price, place a limit order.
Hit the Open button and eToro will execute your order.
If you want additional info about investing in stocks on eToro, watch the helpful video below:
As of Sep 29, 2023, it costs $0.30 to buy one share of Ibio stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.15, you can buy 0.5 shares of IBIO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.